Topics & News
-
open_in_new NEWTakanori ABE was selected as Silver by IAM Patent 1000 2026 in the category of Litigation.
-
open_in_new NEWABE & PARTNERS was selected as Silver by IAM Patent 1000 2026 in the category of Litigation.
-
Takanori ABE gave a lecture entitled "Medical Standard of Care" at Faculty of Medicine, Osaka University.
-
Takanori ABE gave a lecture entitled "Legal Issues in the Corporate Activities" at Japan Intellectual Property Association (Osaka).
-
Takanori ABE gave a lecture entitled "How to react to IP Disputes" at Japan Intellectual Property Association (Osaka).
-
open_in_new NEWABE & PARTNERS has been ranked Tier2 in Japan by Asian Legal Business' ALB IP Rankings 2026.
-
open_in_new NEWABE & PARTNERS was selected as a finalist for ALB Japan Law Award 2026 in the Eight categories.
-
US Law Firm has visited ABE & PARTNERS.
-
open_in_newTakanori ABE was selected as a finalist for Life Sciences IP Review's LSPN Awards USA 2026 in the category of Cross-Border Patent Counsel of the Year Award.
-
open_in_newABE & PARTNERS was selected as a finalist for Life Sciences IP Review's LSPN Awards USA 2026 in the category of Cross-Border Collaboration Partner of the Year.
-
UK Law Firm has visited ABE & PARTNERS.
-
ABE & PARTNERS represented Regeneron Pharmaceuticals against Fuji Pharma in a patent infringement preliminary injunction case at the Osaka District Court. The preliminary injunction case has been withdrawn following a settlement.
-
ABE & PARTNERS wins Multidisciplinary Law Firm of The Year - Osaka - Japan at the International Elite 100 Global Award.
- 1
2026